Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effects
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effects ; volume:18 ; number:1 ; day:20 ; month:1 ; year:2025 ; pages:1-21 ; date:12.2025
Journal of hematology & oncology ; 18, Heft 1 (20.1.2025), 1-21, 12.2025
- Creator
-
Dona, Ada Alice
Tandoh, Theophilus
Nigam, Lokesh
Singer, Mahmoud
Caserta, Enrico
Murtadha, Mariam
Zhu, Yinghui
Moloudizargari, Milad
Sharma, Preeti
Napolitano, Ottavio
Winchester, Janet
Chowdhury, Arnab
Pozhitkov, Alex
Sanchez, James F.
Vahed, Hawa
Marcucci, Guido
Coffey, Matt
Nuovo, Gerard
Sborov, Douglas W.
Pichiorri, Flavia
Hofmeister, Craig C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-024-01645-3
- URN
-
urn:nbn:de:101:1-2503082059372.543822321199
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dona, Ada Alice
- Tandoh, Theophilus
- Nigam, Lokesh
- Singer, Mahmoud
- Caserta, Enrico
- Murtadha, Mariam
- Zhu, Yinghui
- Moloudizargari, Milad
- Sharma, Preeti
- Napolitano, Ottavio
- Winchester, Janet
- Chowdhury, Arnab
- Pozhitkov, Alex
- Sanchez, James F.
- Vahed, Hawa
- Marcucci, Guido
- Coffey, Matt
- Nuovo, Gerard
- Sborov, Douglas W.
- Pichiorri, Flavia
- Hofmeister, Craig C.
- SpringerLink (Online service)
Other Objects (12)
Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models
Proteasome inhibition: the dawn of novel therapies in multiple myeloma
Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma
Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma
MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors
Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma
The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma
Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models
Proteasome inhibition: the dawn of novel therapies in multiple myeloma
Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma
Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma
MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors
Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma
The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma
Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models
Proteasome inhibition: the dawn of novel therapies in multiple myeloma
Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma
Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma
MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors
Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma